• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ortin Global Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 17472.0
  • ISIN : INE749B01020
15.35 0 (2.88%)
  • As on 01 Aug 2026 (EOD)

  • Today’s Low

    14.92

  • Today’s High

    15.60

  • Open

    15.60

  • Perv Close

    14.92

  • 52W Low

    10.66

  • 52W High

    21.30

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    12.48

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.53

  • Debt-Equity Ratio

    2.88

  • AGM Date

    31-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    12.48

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.13

  • BV (₹)

    1.50

  • Sales( ₹ in Cr.)

    0.10

  • NP (in Cr.)

    -0.74

  • NP Var(%)

    14.0

  • Div%

    0.0

  • CPS (₹)

    -0.90

  • EPS (₹)

    -0.90

  • Traded Value (₹ in Lakhs)

    12.68

  • 52 Week High

    21.30

  • 52 Week Low

    10.66

  • Price BSE

    16.0

  • Price NSE

    15.00

  • Market Capital( in Cr.)

    12.68

  • P/C Ratio

    -17.60

  • P/E Ratio

    -17.60

  • Price Vs.BV

    -0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 0.34 2.11 6.02 8.23 8.17 197.39
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.34 2.11 6.02 8.23 8.17 197.39
Other Income 0.06 0.17 0.04 0.19 0.05 0.19
Stock Adjustments -0.03 -1.33 0.50 -0.05 0.13 10.53
Total Income 0.37 0.95 6.56 8.37 8.35 208.11
EXPENDITURE :            
Raw Materials 0.18 2.38 3.89 4.61 4.08 165.15
Power and Fuel Cost 0.05 0.17 0.24 0.22 0.11 5.39
Employee Cost 0.09 0.49 0.68 0.74 0.85 4.72
Other Manufacturing Expenses 0.06 0.50 0.29 0.42 0.55 20.66
Selling and Administration Expenses 0.73 1.30 0.72 1.42 1.06 4.71
Miscellaneous Expenses 0.08 2.48 0.20 0.41 0.40 1.60
Employee Benefit Expenses 0.09 0.49 0.68 0.74 0.85 4.72
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1.19 7.31 6.03 7.81 7.05 202.23
Operating Profit -0.83 -6.37 0.54 0.57 1.29 5.88
Interest 0.00 0.48 0.40 0.81 0.87 3.21
Gross Profit -0.83 -6.85 0.14 -0.24 0.42 2.67
Depreciation 0.01 0.23 0.25 0.29 0.29 1.96
Profit Before Tax -0.84 -7.08 -0.11 -0.53 0.13 0.71
Current Tax 0.00 1.29 0.00 0.00 0.06 1.06
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 -0.33 -0.02 -0.13 -0.87 0.23
Reported Net Profit -0.85 -8.04 -0.09 -0.40 0.95 -0.56
Extraordinary Items 0.02 -1.76 -0.02 0.00 0.00 -0.01
Adjusted Net Profit -0.87 -6.28 -0.07 -0.40 0.95 -0.55
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -4.38 -0.71
P & L Balance brought forward -5.95 2.09 2.18 2.58 6.02 7.30
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -6.80 -5.95 2.09 2.18 2.58 6.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.04 -9.89 -0.12 -0.49 1.16 -0.33
Earnings Per Share(Adj)-Unit Curr -1.04 -9.89 -0.12 -0.49 1.16 -0.33
Book Value 2.43 3.47 13.36 13.47 13.97 14.06
Book Value(Adj)-Unit Curr 2.43 3.47 13.36 13.47 13.97 14.06

Shareholding Pattern

  • Promoter Group

    1.23%

  • Public Share Holding

    98.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100,300 1.23 100,300 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 100,300 1.23 100,300 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 146,676 1.80 146,676 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 146,676 1.80 146,676 2
2] Non Institution
Bodies Corporate 177,124 2.18 176,260 35
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 176,785 2.17 176,785 54
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 141,908 1.75 141,428 171
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,960,778 36.41 2,960,778 44
Individuals holding nominal share capital up to Rs. 1 lakh 4,427,821 54.45 4,345,906 11,073
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,884,416 96.96 7,801,157 11,377
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,131,392 100.00 8,048,133 11,383

Company Background

Ortin Global LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ortin Global Ltd
  • BSE Code : 17472.0
  • ISIN : INE749B01020

  • Incorporation Year

    1986

  • Registered Office

    D No 1-8-B4 Ground Floor F3
    HIG Block-4 Street No 3, Hyderabad,
    Telangana-500044

  • Telephone

  • FAX

  • Chairman

    Sarang Balbhimrao Patodekar

  • Managing Director

    S Murali Krishna Murthy

  • Company Secretary

    Madhu Solanki

  • Auditor

    Mathesh & Ramana

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Ortin Global Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ortin Global 15.59 0.38 0.34 -17.13 0.00
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77